Zymeworks

company

Number of Lead Investors

Number of Investors

Zymeworks is funded by 23 investors. BDC Healthcare Venture and Lumira Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
BDC Healthcare Venture	Yes	Series A
Lumira Ventures	Yes	Series A
CTI Capital	Yes	Series Unknown
Amplitude Venture Capital	-	Post-IPO Equity
Business Development Bank of Canada	-	Post-IPO Equity
Citigroup Global Markets Canada Inc	-	Post-IPO Equity
MTS Health Partners	-	Post-IPO Equity
Paradigm Capital	-	Post-IPO Equity
Raymond James	-	Post-IPO Equity
Wells Fargo Securities Canada	-	Post-IPO Equity
Northleaf Capital Partners	-	Series A
BDC Venture Capital	-	Series A
Brace Pharma	-	Series A
Celgene	-	Series A
CTI Life Sciences Fund	-	Series A
Eli Lilly	-	Series A
Fonds de solidarité FTQ	-	Series A
Merlin Nexus	-	Series A
Perceptive Advisors	-	Series A
Robert Simon	-	Series A
Teralys Capital	-	Series A
Advanced Biotechnologies Venture Fund	-	Series Unknown
WUTIF	-	Seed